UPDATE: Biotech Index, ETF’s reach 61.8% Fibonacci Retracement of Feb-Apr Decline
On April 9, we pointed out a key Fibonacci Retracement cluster of support on the S&P SPDR Biotech ETF, $XBI (also generally corresponding with similar…
On April 9, we pointed out a key Fibonacci Retracement cluster of support on the S&P SPDR Biotech ETF, $XBI (also generally corresponding with similar…
Following in line with yesterday’s chart on the # of 52-week highs, today’s ChOTD looks at the median distance from 52-week highs among S&P 100 and…
Today’s ChOTD comes out of the bottomless “divergence barrel”. This one looks at the % of 52-week highs among S&P 100 constituents vs. Russell 2000…
This week we presented a series of charts outlining how recent index highs pass the so-called market top “look test”. By that we mean that…
We’ve been discussing the setup in the London FTSE 100 for several months now, pondering its potential to finally break out to new post-2000 highs…
This week, our ChOTD’s have been a series demonstrating why recent index highs (Russell 2000, Dow, S&P 400 Midcap and S&P 500) pass the so-called market top “look test”. To qualify, we…
Continuing our series on why recent index highs pass the so-called market top “look test”, today we look at the S&P 500 (previously we looked…
Today’s ChOTD in our series on how recent index highs pass the so-called market top “look test” focuses on the S&P 400 Midcap index (previously,…
Continuing this week’s series of charts outlining how recent index highs pass the so-called market top “look test”, today we focus on the Dow Jones…
My401kPro’s June update is in. Check out the Commentary, current Equity Allocation and your Fund Rankings: http://www.My401kPro.com